Summary
David Pacitti, formerly President and Head of the Americas at Siemens Healthineers, is set to become the new CEO of Avanos Medical. Pacitti brings extensive experience in the healthcare sector, having held leadership positions at Siemens Healthineers and Abbott Vascular. This appointment marks a new chapter for Avanos Medical, with Pacitti at the helm to guide its future growth and innovation within the medical technology landscape.
Join leading healthcare providers who trust TrueNAS for reliable and secure data management.
** Main Story**
Avanos Medical, you know, that company known for its medical tech solutions, just announced a new CEO. On March 17th, 2025, they revealed David Pacitti would be taking the helm, succeeding Joe Woody, who retired at the end of last year. Michael Greiner, who stepped in as interim CEO, will be passing the baton on April 14th, 2025. It’s a pretty big deal for Avanos, really signaling a fresh chapter with Pacitti in charge. Important to note: this is current as of March 20, 2025, but you know how things can change.
Pacitti: A Healthcare Heavyweight
So, Pacitti isn’t exactly new to this. He’s got over two decades under his belt in the healthcare sector. He was most recently President of Siemens Medical Solutions USA, Inc., and also headed up the Americas for Siemens Healthineers. Essentially, he was calling the shots for their growth and operations in North and Latin America. That meant overseeing a huge portfolio, from imaging to diagnostics. Quite the resume, wouldn’t you agree?
From Stents to Strategic Growth: A Look Back
Before Siemens, Pacitti spent a good chunk of his career at Abbott Vascular. He was Division VP there, managing sales and marketing in North America. If you’re in the medical device world you probably remember Pacitti’s role in launching some crucial product lines, including Abbott Vascular’s first drug-eluting stent. From 2009 to 2013 he was Vice President of Commercial Operations, and before that VP of Global Marketing from 2006 to 2009. His journey at Abbott actually started after they acquired Guidant Corp, where he’d been since ’95. That’s quite the track record, wouldn’t you say?
Avanos: All About the Patient
Avanos Medical, at its heart, is focused on creating medical devices that improve patient outcomes. They really concentrate on two main areas: Chronic Care and Pain Management. In chronic care, they’re providing essential support for nutrition, whether in the hospital or at home. And in pain management, they’re trying to reduce reliance on opioids. Because let’s be honest, we all know how bad that can be.
For instance, a friend of mine had surgery last year, and she was amazed at how much less pain medication she needed thanks to some of the new recovery techniques.
A Promising Outlook
The board at Avanos is super excited about Pacitti. Gary Blackford, the board chair, said they’re confident he’ll lead the company to new heights and solidify their position in the industry. Pacitti seems just as enthusiastic. He said he’s honored to lead such a “dynamic organization” and is eager to build on their success. In other words, he wants to drive innovation and keep the focus on patients, which is a smart move. It aligns perfectly with Avanos’s core values.
Plus, he’s involved in a ton of other organizations, like AdvaMed and the Siemens Foundation, which shows he’s committed to the bigger healthcare picture. And, you know, with a degree from Villanova and an MBA from the University of Maryland, he’s clearly got the academic chops to back it all up. All in all? It looks like Avanos Medical is in good hands. I’m keen to see how things develop over the next couple of years, how will they innovate on what they already have?
Pacitti’s experience with drug-eluting stents at Abbott Vascular is certainly noteworthy. Considering the current focus on personalized medicine, it will be interesting to observe if Avanos Medical expands into similar targeted therapies within their chronic care and pain management solutions under his leadership.
That’s a great point! The move towards personalized medicine is certainly transforming healthcare. It will be interesting to see how Pacitti’s experience with targeted therapies might influence Avanos Medical’s approach to chronic care and pain management solutions, perhaps leading to more individualized treatment plans.
Editor: MedTechNews.Uk
Thank you to our Sponsor Esdebe
Pacitti’s experience overseeing growth in North and Latin America at Siemens Healthineers suggests a strong understanding of diverse healthcare markets. It will be interesting to see if Avanos Medical expands its global reach, particularly in emerging markets, under his leadership.